BAM
CRL icon

Bruderman Asset Management’s Charles River Laboratories CRL Stock Holding History

Bruderman Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-845
Closed -$59K – 425
2015
Q2 		$59K Sell
845
-195
-19% -$14.4K 0.02% 202
2015
Q1 		$82K Buy
+1,040
New +$76.7K 0.03% 173

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bruderman Asset Management's CRL Position: Q3 2015 in Review

Bruderman Asset Management sold out of Charles River Laboratories (CRL) in Q3 2015, closing a stake of 845 shares — an estimated $59K sold.

Bruderman Asset Management first reported a position in CRL in Q1 2015 and held it in 2 quarters. The position peaked at $82K in Q1 2015. 258 funds tracked by Wall St. Rank hold CRL as of Q3 2015.

  • Bruderman Asset Management reported no remaining Charles River Laboratories position as of Q3 2015 after selling out during the quarter.
  • Bruderman Asset Management sold 845 Charles River Laboratories shares in Q3 2015, an estimated $59K.
  • Bruderman Asset Management first reported a position in Charles River Laboratories in Q1 2015 and held it in 2 quarters.
  • Bruderman Asset Management's Charles River Laboratories position peaked at $82K in Q1 2015.
  • 258 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2015.

Based on Bruderman Asset Management's 13F filing for Q3 2015, filed 19 Nov 2015.